Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Background High plasma HIV-1 RNA concentrations are associated with increased risk of HIV-1 transmission. Initiation of antiretroviral therapy (ART) reduces plasma HIV-1 concentrations, but little empiric data are available on the rate of sexual HIV-1 transmission from persons receiving ART. Methods 3381 African heterosexual HIV-1 serodiscordant couples were followed prospectively for up to 24 months. At enrollment, HIV-1 infected partners had CD4 counts ≥250 cells/mm3 and did not meet country guidelines for ART initiation; during follow-up, CD4 counts were measured every 6 months and ART initiated following national guidelines. HIV-1 uninfected partners were tested for HIV-1 every 3 months. We compared genetically-linked HIV-1 transmission rates by ART initiation. Results 349 (10%) HIV-1 infected partners initiated ART, at a median CD4 count of 198 cells/mm3. Only one of 103 linked HIV-1 transmissions was observed from an HIV-1 infected partner who had initiated ART corresponding to HIV-1 transmission rates of 0.37 versus 2.24 per 100 person-years for those who had initiated versus not initiated ART, respectively (adjusted incidence rate ratio 0.08, 95% confidence interval 0.002–0.57, p=0.004). After ART initiation, plasma HIV-1 RNA concentrations decreased significantly (from median 4.88 to <2.38 log10 copies/mL, p<0.001) as did unprotected sex (6.2% of visits before to 3.7% of visits after ART initiation, p=0.03). Among those not on ART, the highest HIV-1 transmission rate (8.79 per 100 person-years) was from HIV-1 infected persons with CD4 counts <200 cells/mm3. In couples in which the HIV-1 infected partner had a CD4 ≥200 cells/mm3, 70% of transmissions occurred when plasma HIV-1 concentrations exceeded 50,000 copies/mL. Conclusions Among African heterosexual couples, ART initiation was followed by a 92% reduction in HIV-1 transmission risk, likely due to significantly reduced plasma HIV-1 levels, and was accompanied by increased self-reported condom use. The highest HIV-1 risk and greatest relative prevention benefit from ART was among couples in which the HIV-1 infected partner had CD4 counts <200 cells/mm3 or plasma HIV-1 RNA concentrations >50,000 copies/mL.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents
(1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-12_part_2-199806151-00003 · Cited by 5,209
Viral Load and Heterosexual Transmission of Human Immunodeficiency Virus Type 1
Quinn, T. C., Wawer, M. J., Sewankambo, N., Serwadda, D., Li, C., Wabwire-Mangen, F., Meehan, M. O., Lutalo, T., & Gray, R. H. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003303421303 · Cited by 3,020
Granich, R. M., Gilks, C. F., Dye, C., De Cock, K. M., & Williams, B. G. (2009) · The Lancet · doi:10.1016/s0140-6736(08)61697-9 · Cited by 1,988
Attia, S., Egger, M., Müller, M., Zwahlen, M., & Low, N. (2009) · AIDS · doi:10.1097/qad.0b013e32832b7dca · Cited by 1,001
Ashley, R. L., Militoni, J., Lee, F., Nahmias, A., & Corey, L. (1988) · Journal of Clinical Microbiology · doi:10.1128/jcm.26.4.662-667.1988 · Cited by 541
Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2.
Celum, C., Wald, A., Lingappa, J. R., Magaret, A. S., Wang, R. S., Mugo, N., Mujugira, A., Baeten, J. M., Mullins, J. I., Hughes, J. P., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0904849 · Cited by 524
Self-citationBunnell, R., Ekwaru, J. P., Solberg, P., Wamai, N., Bikaako-Kajura, W., Were, W., Coutinho, A., Liechty, C., Madraa, E., Rutherford, G., et al. (2006) · AIDS · doi:10.1097/01.aids.0000196566.40702.28 · Cited by 463
Relation between HIV viral load and infectiousness: a model-based analysis
Wilson, D. P., Law, M. G., Grulich, A. E., Cooper, D. A., & Kaldor, J. M. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61115-0 · Cited by 362
Vernazza, P. L., Troiani, L., Flepp, M. J., Cone, R. W., Schock, J., Roth, F., Boggian, K., Cohen, M. S., Fiscus, S. A., & Eron, J. J. (2000) · AIDS · doi:10.1097/00002030-200001280-00006 · Cited by 271
Treatment to Prevent Transmission of HIV‐1
Cohen, M. S., & Gay, C. L. (2010) · Clinical Infectious Diseases · doi:10.1086/651478 · Cited by 176
Lingappa, J. R., Baeten, J. M., Wald, A., Hughes, J. P., Thomas, K. K., Mujugira, A., Mugo, N., Bukusi, E. A., Cohen, C. R., Katabira, E. T., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(09)62038-9 · Cited by 152
Self-citationInitiation of antiretroviral therapy leads to a rapid decline in cervical and vaginal HIV-1 shedding
Graham, S. M., Holte, S. E., Peshu, N. M., Richardson, B. A., Panteleeff, D. D., Jaoko, W. G., Ndinya-Achola, J. O., Mandaliya, K. N., Overbaugh, J. M., & McClelland, R. S. (2007) · AIDS · doi:10.1097/qad.0b013e32801424bd · Cited by 136
Marcelin, A., Tubiana, R., Lambert-Niclot, S., Lefebvre, G., Dominguez, S., Bonmarchand, M., Vauthier-Brouzes, D., Marguet, F., Mousset‐Siméon, N., Peytavin, G., et al. (2008) · AIDS · doi:10.1097/qad.0b013e32830abdc8 · Cited by 128
Modjarrad, K., Chamot, E., & Vermund, S. H. (2008) · AIDS · doi:10.1097/qad.0b013e328312c756 · Cited by 113
Eisele, T. P., Mathews, C., Chopra, M., Lurie, M. N., Brown, L. F., Dewing, S., & Kendall, C. (2008) · AIDS and Behavior · doi:10.1007/s10461-008-9473-2 · Cited by 82
Quantifying HIV for Monitoring Antiretroviral Therapy in Resource‐Poor Settings
Stevens, W. S., Scott, L. E., & Crowe, S. M. (2010) · The Journal of Infectious Diseases · doi:10.1086/650392 · Cited by 68
Self-citationHIV treatment, injection drug use, and illicit drug policies.
Wood, E., Kerr, T., & Montaner, J. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61025-3 · Cited by 31
Cited by
Prevention of HIV-1 infection with early antiretroviral therapy.
Cohen, M. S., Chen, Y. Q., McCauley, M., Gamble, T., Hosseinipour, M. C., Kumarasamy, N., Hakim, J. G., Kumwenda, J., Grinsztejn, B., Pilotto, J. H. S., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1105243 · Cited by 6,873
Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.
Grant, R. M., Lama, J. R., Anderson, P. L., McMahan, V., Liu, A. Y., Vargas, L., Goicochea, P., Casapía, M., Guanira-Carranza, J. V., Ramirez-Cardich, M. E., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1011205 · Cited by 5,096
“Current infection with hepatitis B virus 7 (1) 6 (<1)”
BackgroundInfluentialAntiretroviral prophylaxis for HIV prevention in heterosexual men and women.
Baeten, J. M., Donnell, D., Ndase, P., Mugo, N. R., Campbell, J. D., Wangisi, J., Tappero, J. W., Bukusi, E. A., Cohen, C. R., Katabira, E., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1108524 · Cited by 3,256
“(%)¶** 59/1569 (4) 73/1576 (5) 60/1572 (4) 52/1573 (3) 62/1569 (4) 73/1571 (5)”
Self-citationGardner, E. M., McLees, M. P., Steiner, J. F., del Rio, C., & Burman, W. J. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq243 · Cited by 1,893
Rodger, A. J., Cambiano, V., Bruun, T., Vernazza, P., Collins, S., van Lunzen, J., Corbelli, G. M., Estrada, V., Geretti, A. M., Beloukas, A., et al. (2016) · JAMA · doi:10.1001/jama.2016.5148 · Cited by 1,431
Metadata
- Authors
- Donnell, D., Baeten, J. M., Kiarie, J., Thomas, K. K., Stevens, W., Cohen, C. R., McIntyre, J., Lingappa, J. R., & Celum, C.
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2010-06
- Volume
- 375
- Issue
- 9731
- Pages
- 2092-2098
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2100430786
- Cited by
- 952
- References
- 17
- FWCI
- 85.12
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.